National Center for Advancing Translational Sciences (NCATS)
Venture Capital
NCATS is a component of the U.S. National Institutes of Health (NIH) established in 2011 to transform the translational science process — speeding the development of new treatments and cures for disease. It funds early-stage biomedical innovation through SBIR/STTR grants and collaborative research programs.
Bethesda, United States · 4+ investments
Pre-Seed
Seed
Early Stage
Biotech
Drug Discovery
Healthcare
Life Sciences
- Headquarters
- Bethesda, United States
- Founded
- 2011
- Website
- ncats.nih.gov
- Total Investments
- 4
- Last Investment
- Oct 2024
- Geographic Focus
- United States
Investment Thesis
Funds translational science innovations that turn research observations into health solutions, primarily through SBIR and STTR programs supporting small businesses commercializing biomedical breakthroughs. Phase I budget waiver amount is $350K.
National Center for Advancing Translational Sciences (NCATS) is a Venture Capital firm based in Bethesda, United States. It has made 4 investments in Biotech and Drug Discovery.
Investment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.